Digital health is poised to revolutionize oncology care, but adoption remains limited—currently accounting for only 3% of oncology care volume. With the digital health market projected to hit $221 billion by 2026 and cancer care costs estimated at $246 billion by 2030, the potential for impact is significant. For pharmaceutical and life science companies, collaboration is essential in developing tools that enhance screening, diagnosis, treatment, and patient engagement. Addressing challenges in technology adoption and regulatory approval will be crucial to unlocking the full potential of digital health in oncology.

In this webinar, we’ll explore:

1. The shift of oncology care to patients' homes
2. How to turn vast amounts of data into actionable insights
3. The role regulators play in advancing digital health and fostering collaboration